Cargando…
Anti-PD-1 mAb pre-radiotherapy (RT) loading dose and fractionated RT induce better tumor-specific immunity and tumor shrinkage than sequential administration in an HPV+ head and neck cancer model
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649308/ http://dx.doi.org/10.1186/2051-1426-3-S2-P314 |
_version_ | 1782401329806704640 |
---|---|
author | Srivastava, Raghvendra M Clump, David A Ferris, Robert L |
author_facet | Srivastava, Raghvendra M Clump, David A Ferris, Robert L |
author_sort | Srivastava, Raghvendra M |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4649308 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46493082015-11-24 Anti-PD-1 mAb pre-radiotherapy (RT) loading dose and fractionated RT induce better tumor-specific immunity and tumor shrinkage than sequential administration in an HPV+ head and neck cancer model Srivastava, Raghvendra M Clump, David A Ferris, Robert L J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649308/ http://dx.doi.org/10.1186/2051-1426-3-S2-P314 Text en Copyright © 2015 Srivastava et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Srivastava, Raghvendra M Clump, David A Ferris, Robert L Anti-PD-1 mAb pre-radiotherapy (RT) loading dose and fractionated RT induce better tumor-specific immunity and tumor shrinkage than sequential administration in an HPV+ head and neck cancer model |
title | Anti-PD-1 mAb pre-radiotherapy (RT) loading dose and fractionated RT induce better tumor-specific immunity and tumor shrinkage than sequential administration in an HPV+ head and neck cancer model |
title_full | Anti-PD-1 mAb pre-radiotherapy (RT) loading dose and fractionated RT induce better tumor-specific immunity and tumor shrinkage than sequential administration in an HPV+ head and neck cancer model |
title_fullStr | Anti-PD-1 mAb pre-radiotherapy (RT) loading dose and fractionated RT induce better tumor-specific immunity and tumor shrinkage than sequential administration in an HPV+ head and neck cancer model |
title_full_unstemmed | Anti-PD-1 mAb pre-radiotherapy (RT) loading dose and fractionated RT induce better tumor-specific immunity and tumor shrinkage than sequential administration in an HPV+ head and neck cancer model |
title_short | Anti-PD-1 mAb pre-radiotherapy (RT) loading dose and fractionated RT induce better tumor-specific immunity and tumor shrinkage than sequential administration in an HPV+ head and neck cancer model |
title_sort | anti-pd-1 mab pre-radiotherapy (rt) loading dose and fractionated rt induce better tumor-specific immunity and tumor shrinkage than sequential administration in an hpv+ head and neck cancer model |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649308/ http://dx.doi.org/10.1186/2051-1426-3-S2-P314 |
work_keys_str_mv | AT srivastavaraghvendram antipd1mabpreradiotherapyrtloadingdoseandfractionatedrtinducebettertumorspecificimmunityandtumorshrinkagethansequentialadministrationinanhpvheadandneckcancermodel AT clumpdavida antipd1mabpreradiotherapyrtloadingdoseandfractionatedrtinducebettertumorspecificimmunityandtumorshrinkagethansequentialadministrationinanhpvheadandneckcancermodel AT ferrisrobertl antipd1mabpreradiotherapyrtloadingdoseandfractionatedrtinducebettertumorspecificimmunityandtumorshrinkagethansequentialadministrationinanhpvheadandneckcancermodel |